Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
1.440
-0.020 (-1.37%)
At close: Apr 1, 2025, 4:00 PM
1.350
-0.090 (-6.25%)
After-hours: Apr 1, 2025, 7:41 PM EST

Armata Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-18.92-69.05-36.92-23.16-22.18
Upgrade
Depreciation & Amortization
1.330.970.891.171.11
Upgrade
Loss (Gain) From Sale of Assets
-0.08---
Upgrade
Stock-Based Compensation
2.890.943.112.883.48
Upgrade
Other Operating Activities
-20.7529.28--1.250.2
Upgrade
Change in Accounts Payable
-3.760.043.670.180.54
Upgrade
Change in Other Net Operating Assets
1.66-9.69-3.23-3.41-1.42
Upgrade
Operating Cash Flow
-37.55-47.42-32.48-23.58-18.27
Upgrade
Capital Expenditures
-1.88-8.14-2.21-1.3-0.82
Upgrade
Sale of Property, Plant & Equipment
-0.01---
Upgrade
Investing Cash Flow
-1.88-8.13-2.21-1.3-0.82
Upgrade
Short-Term Debt Issued
----0.72
Upgrade
Long-Term Debt Issued
34.8954.03---
Upgrade
Total Debt Issued
34.8954.03--0.72
Upgrade
Net Debt Issued (Repaid)
34.8954.03--0.72
Upgrade
Issuance of Common Stock
0.130.0144.5226.9323.06
Upgrade
Repurchase of Common Stock
-0.06-0.04---
Upgrade
Other Financing Activities
---0.5-1.41-0.57
Upgrade
Financing Cash Flow
34.9653.9944.0225.5223.21
Upgrade
Net Cash Flow
-4.47-1.579.320.644.12
Upgrade
Free Cash Flow
-39.43-55.57-34.69-24.88-19.09
Upgrade
Free Cash Flow Margin
-762.08%-1226.91%-629.85%-556.08%-2320.05%
Upgrade
Free Cash Flow Per Share
-0.67-1.54-1.01-1.03-1.16
Upgrade
Levered Free Cash Flow
-29.4-27.75-24.24-16.82-9.83
Upgrade
Unlevered Free Cash Flow
-22.69-26.11-24.24-16.78-9.44
Upgrade
Change in Net Working Capital
-1.5-5.692.934.64-0.29
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q